About this event

  • Date and time Mon 23 May 2022 from 6:00pm to 7:45pm
  • Location Online
  • Organised by Ophthalmology

This is an on-demand recording of an in-person event. To attend this event in person, please click here.

This meeting will inform delegates of the latest thinking in the management of intraocular inflammation. Expert speakers in this field will discuss the next five years of intraocular inflammation and explore what is likely to come into clinical practice during that time.

This evening event will cover state-of-the-art topics in intraocular inflammation. Each speaker has been asked to describe best practices in the diagnosis and management of ocular inflammatory diseases. In addition, they will predict which new drugs and technology are likely to come into clinical practice in the near future.

During this meeting delegates will:

  • Appreciate the current best practices for intraocular inflammation
  • Understand how the best practices will change in the near future
  • Learn about new drugs and technology upcoming for intraocular inflammation

Join in the conversation online 
Follow us on Twitter: @RoySocMed

This is a pre-recorded webinar that will be available three days after the live in-person event on Wednesday 19 May 2022, taking place at the RSM in London. You will be able to view the webinar whenever you like, up to 60 days from when it’s made available. Registered delegates will receive the link via email on Saturday 22 May 2022 to watch this on-demand webinar. 

Key speakers

Professor Alastair Denniston

Consultant Ophthalmologist and Honorary Professor, University Hospitals Birmingham NHS Foundation Trust

Speaker's biography

Professor Alastair Denniston is a Consultant Ophthalmologist specialising in uveitis at University Hospitals Birmingham NHS Foundation Trust, one of the UK’s largest acute healthcare organisations. His work focuses on use of health data research and the application of digital healthcare (including artificial intelligence) to improve patient care in the ‘real world’. Professor Denniston leads a team committed to ensuring that the best innovation within the broad field of ‘artificial intelligence’ is translated safely, efficiently, equitably and inclusively to patients. This includes improving the design and reporting of clinical trials in this area (CONSORT-AI and SPIRIT-AI), highlighting issues of representativeness including the risk of health data poverty; developing tools to support safe deployment (including validation datasets); and working with regulators and other stake-holder groups to support the best of these innovations right through the implementation pathway to routine patient care and public health. Professor Denniston has a particular interest in the use of routinely collected data and digital innovation to tackle sight-threatening disease. He is the Director of INSIGHT, the UK’s Health Data Research Hub for Eye Health which is focused on eye disease and its application to wider health, including diabetes and dementia (unlocking the power of ‘oculomics’). INSIGHT enables the use of anonymised large-scale data and advanced analytics, including artificial intelligence, to develop new insights in disease detection, diagnosis, treatments and personalised healthcare. Professor Denniston is a Member of the UK Government’s Regulatory Horizons Council, AI Theme Lead for the Centre for Regulatory Science and Innovation (Birmingham, UK), and part of the UK’s Biomedical Research Centre for Ophthalmology (Moorfields Eye Hospital/UCL).

Professor Carlos Pavesio

Ophthalmology, Moorfields Eye Hospital

Agenda

View the programme

Welcome and introduction

Mr Miles Stanford, Consultant Ophthalmologist, St Thomas’ Hospital

The epidemiology of intraocular inflammation in the UK – the use of big data

Dr Tasanee Braithwaite, Consultant Ophthalmologist (Uveitis and Neuro-Ophthalmology), The Medical Eye Unit, Guy’s and St Thomas’ NHS Foundation Trust

New methods of imaging in diagnosis and management

Professor Alastair Denniston, Consultant Ophthalmologist and Honorary Professor, University Hospitals Birmingham NHS Foundation Trust

Paediatric uveitis; Current practice and future potential

Mr Harry Petrushkin, Consultant, Moorfields Eye Hospital

Advances in local therapies

Professor Carlos Pavesio, Ophthalmology, Moorfields Eye Hospital

Developments in systemic therapies

Mr William Tucker, Consultant Ophthalmologist, Moorfields Eye Hospital NHS Foundation Trust

Panel discussion
Close of meeting

Location

Online

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted. 

This is a pre-recorded webinar that will be available three days after the live in-person event on Thu 19 May 2022, taking place at the RSM in London. You will be able to view the webinar whenever you like, up to 60 days from when it’s made available. Registered delegates will receive the link via email on Sat 21 May 2022  to watch this on-demand webinar. 

Webinar recordings will be available for registered delegates up to 60 days after the live webinar, via Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.